Abstract A080: Systematic PDX-based drug screening reveals genotype-specific vulnerabilities and therapeutic combinatorial opportunities in colorectal cancer
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444693
Cites:
Cited by:
Related to:
